Autor Título Original / Colaboración Selecciona una opción Original Colaboración Año Selecciona un año2015201620172018201920202021202220232024 Cuartil Selecciona un cuartilD1Q1Q2Q3Q4 Tipo Selecciona un tipo#N/DArticleArtículoBook ChapterBook ReviewClinical TrialCommentaryCorrectionData PaperEditorialEditorial MaterialLetterProceedings PaperReprintReview Revista The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant Autores: Lopez, MG; Chiner-Oms, A; de Viedma, DG; Ruiz-Rodriguez, P; Bracho, MA; Cancino-Munoz, I; D'Auria, G; de Marco, G; Garcia-Gonzalez, N; Goig, GA; Gomez-Navarro, I; Jimenez-Serrano, S; Martinez-Priego, L; Ruiz-Hueso, P; Ruiz-Roldan, L; Torres-Puente, M; Alb Mapping the human genetic architecture of COVID-19 Autores: Tagging, ANIM (Garcia, F) Implementing Personalized Medicine in COVID-19 in Andalusia: An Opportunity to Transform the Healthcare System Autores: Dopazo, J; Maya-Miles, D; Garcia, F; Lorusso, N; Calleja, MA; Pareja, MJ; Lopez-Miranda, J; Rodriguez-Bano, J; Padillo, J; Tunez, I; Romero-Gomez, M Increased risk of severe clinical course of COVID-19 in carriers of HLA-C*04:01 Autores: Weiner, J; Suwalski, P; Holtgrewe, M; Rakitko, A; Thibeault, C; Muller, M; Patriki, D; Quedenau, C; Kruger, U; Ilinsky, V; Popov, I; Balnis, J; Jaitovich, A; Helbig, ET; Lippert, LJ; Stubbemann, P; Real, LM; Macias, J; Pineda, JA; Fernandez-Fuertes, M; Wa Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality Autores: Nakanishi, T; Pigazzini, S; Degenhardt, F; Cordioli, M; Butler-Laporte, G; Maya-Miles, D; Bujanda, L; Bouysran, Y; Niemi, MEK; Palom, A; Ellinghaus, D; Khan, A; Martinez-Bueno, M; Rolker, S; Amitrano, S; Tato, LR; Fava, F; Spinner, CD; Prati, D; Bernardo, Interleukin-1 and interleukin-6 inhibition in patients with COVID-19 and hyperinflammation. Autores: Salvatierra, J; Aomar-Millan, IF; Hernandez-Quero, J Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID-19 pneumonia and moderate hyperinflammation. A retrospective cohort study: reply.. Autores: Aomar-Millan, IF; Salvatierra, J; Hernandez-Quero, J < 1 2 … 26 27 28 … 38 39 >